Nuo Therapeutics, Inc. also files under NUOT, CMXI, CMXI.OB, GTF, CTF, GFT; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Jorden David Emerson | CEO/CFO, Director | Buy(P) | 8K | $1.09 | $9K |
| Aug 27, 2026 | Jorden David Emerson | CEO/CFO, Director | Buy(P) | 789 | $1.07 | $844 |
| Jun 30, 2026 | Pittman Scott M. | Director, 10% Owner | Tax withholding(F) | 40K | $1.01 | $40K |
| Jun 30, 2026 | Winzer C Eric | Director | Option exercise(M) | 40K | — | $0 |
| Jun 30, 2026 | Winzer C Eric | Director | Option exercise(M) | 40K | $1.00 | $40K |
| Jun 30, 2026 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 163K | — | $0 |
| Jun 30, 2026 | Winzer C Eric | Director | Tax withholding(F) | 40K | $1.01 | $40K |
| Jun 30, 2026 | Jorden David Emerson | CEO/CFO, Director | Tax withholding(F) | 161K | $1.01 | $163K |
| Jun 30, 2026 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 40K | — | $0 |
| Jun 30, 2026 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 40K | $1.00 | $40K |
| Jun 30, 2026 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 163K | $1.00 | $163K |
| Jun 29, 2026 | Jorden David Emerson | CEO/CFO, Director | Grant(A) | 125K | — | $0 |
| Jun 29, 2026 | Mintz Paul | Director | Grant(A) | 30K | — | $0 |
| Jun 29, 2026 | Clausen Peter | CSO/COO | Grant(A) | 65K | — | $0 |
| Jun 29, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 29, 2026 | Winzer C Eric | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2026 | Jorden David Emerson | CEO/CFO, Director | Grant(A) | 13K | $1.10 | $15K |
| May 29, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 17K | $1.50 | $26K |
| May 29, 2026 | Pittman Scott M. | Director, 10% Owner | Disposed to issuer(D) | 8K | $1.50 | $11K |
| May 29, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 7K | $1.50 | $11K |
| May 29, 2026 | Pittman Scott M. | Director, 10% Owner | Disposed to issuer(D) | 37K | $1.50 | $55K |
| May 29, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 18K | $1.50 | $26K |
| Jan 23, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 37K | $1.50 | $55K |
| Jan 23, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 8K | $1.50 | $11K |
| Jan 23, 2026 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 30K | $1.50 | $45K |
| Jan 1, 2026 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 125K | $0.40 | $50K |
| Jan 1, 2026 | Jorden David Emerson | CEO/CFO, Director | Tax withholding(F) | 25K | $1.97 | $50K |
| Dec 17, 2025 | Winzer C Eric | Director | Option exercise(M) | 69K | — | $0 |
| Dec 17, 2025 | Winzer C Eric | Director | Option exercise(M) | 69K | $0.40 | $28K |
| Dec 17, 2025 | Winzer C Eric | Director | Tax withholding(F) | 14K | $2.00 | $28K |
| Dec 9, 2025 | Mintz Paul | Director | Tax withholding(F) | 9K | $2.20 | $20K |
| Dec 9, 2025 | Mintz Paul | Director | Option exercise(M) | 50K | $0.40 | $20K |
| Nov 28, 2025 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 200K | $1.50 | $300K |
| Aug 1, 2025 | Winzer C Eric | Director | Option exercise(M) | 120K | $0.40 | $48K |
| Aug 1, 2025 | Mintz Paul | Director | Tax withholding(F) | 20K | $1.74 | $35K |
| Aug 1, 2025 | Mintz Paul | Director | Option exercise(M) | 88K | $0.40 | $35K |
| Aug 1, 2025 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 93K | $0.40 | $37K |
| Aug 1, 2025 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 100K | $0.40 | $40K |
| Aug 1, 2025 | Jorden David Emerson | CEO/CFO, Director | Tax withholding(F) | 21K | $1.74 | $37K |
| Aug 1, 2025 | Winzer C Eric | Director | Tax withholding(F) | 28K | $1.74 | $48K |
| Jul 31, 2025 | Clausen Peter | CSO/COO | Option exercise(M) | 184K | $0.40 | $74K |
| Jul 30, 2025 | Sheedy Charles E | 10% Owner | Buy(P) | 133K | $1.50 | $200K |
| Jul 30, 2025 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 4K | $1.50 | $6K |
| Nov 15, 2024 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 63K | $0.40 | $25K |
| Nov 15, 2024 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 33K | $0.50 | $17K |
| Nov 15, 2024 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 122K | $0.40 | $49K |
| Sep 18, 2024 | Sheedy Charles E | 10% Owner | Buy(P) | 125K | $0.75 | $94K |
| Jul 17, 2024 | Winzer C Eric | Director | Grant(A) | 40K | $0.33 | $13K |
| Jul 17, 2024 | Mintz Paul | Director | Grant(A) | 25K | $0.33 | $8K |
| Jul 17, 2024 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 40K | $0.33 | $13K |
| May 20, 2024 | Sheedy Charles E | 10% Owner | Buy(P) | 100K | $0.75 | $75K |
| May 20, 2024 | Clausen Peter | CSO/COO | Grant(A) | 15K | $0.75 | $11K |
| May 20, 2024 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 135K | $0.75 | $101K |
| Dec 19, 2023 | Sheedy Charles E | 10% Owner | Buy(P) | 150K | $0.50 | $75K |
| Dec 19, 2023 | Clausen Peter | CSO/COO | Grant(A) | 20K | $0.50 | $10K |
| Dec 19, 2023 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 600K | $0.50 | $300K |
| Aug 1, 2023 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 100K | $2.00 | $200K |
| Aug 1, 2023 | Sheedy Charles E | 10% Owner | Buy(P) | 63K | $2.00 | $125K |
| Aug 1, 2023 | Clausen Peter | CSO/COO | Grant(A) | 25K | $2.00 | $50K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 20K | $1.50 | $30K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 30K | $1.50 | $45K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 27K | $1.50 | $41K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 14K | $1.50 | $20K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 30K | $1.50 | $45K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 7K | $1.50 | $11K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 5K | $1.50 | $8K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 10K | $1.50 | $15K |
| Nov 9, 2022 | Jorden David Emerson | CEO/CFO, Director | Sell(S) | 20K | $1.50 | $30K |
| Jun 6, 2022 | Clausen Peter | CSO/COO | Grant(A) | 275K | — | $0 |
| Apr 29, 2022 | Jorden David Emerson | CEO/CFO, Director | Grant(A) | 11K | $1.00 | $11K |
| Apr 29, 2022 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 100K | $1.00 | $100K |
| Apr 29, 2022 | Sheedy Charles E | 10% Owner | Buy(P) | 805K | $1.00 | $805K |
| Apr 29, 2022 | Clausen Peter | CSO/COO | Grant(A) | 25K | $1.00 | $25K |
| Mar 4, 2022 | Mintz Paul | Director | Grant(A) | 75K | — | $0 |
| Mar 4, 2022 | Mintz Paul | Director | Grant(A) | 27K | — | $0 |
| Mar 4, 2022 | Winzer C Eric | Director | Grant(A) | 75K | — | $0 |
| Mar 4, 2022 | Winzer C Eric | Director | Grant(A) | 37K | — | $0 |
| Mar 4, 2022 | Clausen Peter | CSO/COO | Grant(A) | 43K | — | $0 |
| Mar 4, 2022 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 33K | — | $0 |
| Mar 4, 2022 | Pittman Scott M. | Director, 10% Owner | Grant(A) | 100K | — | $0 |
| Mar 4, 2022 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 33K | — | $0 |
| Mar 4, 2022 | Jorden David Emerson | CEO/CFO, Director | Grant(A) | 67K | — | $0 |
| Mar 4, 2022 | Jorden David Emerson | CEO/CFO, Director | Grant(A) | 125K | — | $0 |
| Jan 1, 2019 | Jorden David Emerson | CEO, CFO, Director | Grant(A) | 125K | — | $0 |
| Dec 31, 2018 | Atinsky Lawrence | Director | Grant(A) | 63K | — | $0 |
| Dec 31, 2018 | Mintz Paul | Director | Grant(A) | 50K | — | $0 |
| Dec 31, 2018 | Pittman Scott M. | Director | Grant(A) | 63K | — | $0 |
| Dec 31, 2018 | Clausen Peter | CSO | Grant(A) | 81K | — | $0 |
| Dec 31, 2018 | Winzer C Eric | Director | Grant(A) | 69K | — | $0 |
| Dec 31, 2018 | Mintz Paul | Director | Option exercise(M) | 50K | — | $0 |
| Dec 31, 2018 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 63K | — | $0 |
| Dec 31, 2018 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 125K | — | $0 |
| Aug 9, 2018 | Mintz Paul | Director | Option exercise(M) | 88K | — | $0 |
| Aug 9, 2018 | Atinsky Lawrence | Director | Grant(A) | 109K | — | $0 |
| Aug 9, 2018 | Jorden David Emerson | CEO, CFO, Director | Grant(A) | 193K | — | $0 |
| Aug 9, 2018 | Winzer C Eric | Director | Grant(A) | 120K | — | $0 |
| Aug 9, 2018 | Clausen Peter | CSO | Grant(A) | 184K | — | $0 |
| Aug 9, 2018 | Mintz Paul | Director | Grant(A) | 88K | — | $0 |
| Aug 9, 2018 | Jorden David Emerson | CEO/CFO, Director | Option exercise(M) | 193K | — | $0 |
| Aug 9, 2018 | Pittman Scott M. | Director, 10% Owner | Option exercise(M) | 122K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Nuo Therapeutics, Inc., SEC CIK 0001091596. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AURX and shows every filing by that issuer (also filed as NUOT, CMXI, CMXI.OB, GTF, CTF, GFT).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AURX